- £218.75bn
- £236.77bn
- $54.07bn
- 78
- 14
- 98
- 73
REG - AstraZeneca PLC - Second Quarter & Half Year Results 2014 <Origin Href="QuoteRef">AZN.L</Origin> - Part 1
AnnouncementREG - DDD Group PLC - Issue of Convertible Unsecured Loan Notes <Origin Href="QuoteRef">AZN.L</Origin> <Origin Href="QuoteRef">DDDL.L</Origin>
AnnouncementREG - AstraZeneca PLC - Notice of Results <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - STRATEGIC RESPIRATORY TRANSACTION WITH ALMIRALL <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - FDA AdCom recommends no CV trial for PAMORA class <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - ASTRAZENECA IN-LICENSES SYNAIRGEN'S SNG001 <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AZ TO PRESENT NEW DATA AT ADA <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementResponse to US FDA CRL for Br
AnnouncementTransaction in Own Shares
AnnouncementAstraZeneca PLC - Seroquel XR
AnnouncementAstraZeneca PLC - Transaction in Own Shares
AnnouncementAstraZeneca PLC - Transaction in Own Shares
AnnouncementAstraZeneca PLC - Transaction in Own Shares
AnnouncementAstraZeneca PLC - Transaction in Own Shares
AnnouncementNotice of Results
AnnouncementTransaction in Own Shares
AnnouncementAstraZeneca PLC - Holding(s) in Company
AnnouncementAstraZeneca PLC Transaction in Own Shares
AnnouncementTransaction in Own Shares
Announcement